Christian Kindl

eBioscience

Affymetrix including eBioscience, an Affymetrix company, works to integrate genomics, proteomics, and pathways biology for the development of personalized medicine. At Affymetrix, we believe that understanding a single cell at the molecular level and how it impacts a living system will enhance diagnostics leading to improved clinical treatments and health outcomes. Affymetrix strives to provide comprehensive solutions to help scientists assess, in a single or multi-parametric manner, the molecular and cellular networks of biology and diseases and translate their findings into clinical decisions for better patient management. eBioscience offers one of the largest selections of antibodies, ELISAs and proteins used in research and clinical applications worldwide to empower new Life Science discoveries. Often first to market with critical reagents, we specialize in providing products for researchers and clinicians in the following areas: Immunology Cell Biology Oncology Stem Cell Biology Clinical Diagnostics